Brief: Pure Biologics Gets Second Advance Of 4.0 Mln Zlotys From National Center For R&D
10/11/2020 10:28
Nov 10 (Reuters) - Pure Biologics SA PUR1.WA :
* GETS SECOND ADVANCE OF 4.0 MILLION ZLOTYS FROM NATIONAL
CENTER
FOR RESEARCH AND DEVELOPMENT UNDER IMPLEMENTATION OF PB0004 DRUG
DEVELOPMENT AND PB005 EXTRACORPOREAL THERAPY
Source text for Eikon: ID:nEM1qVQjYa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects